Related references
Note: Only part of the references are listed.Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
Bianza Moise Bakadia et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
COVID-19 vaccines: The status and perspectives in delivery points of view
Jee Young Chung et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Antiviral drugs in aquatic environment and wastewater treatment plants: A review on occurrence, fate, removal and ecotoxicity
Christina Nannou et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2020)
Analysis, occurrence and removal of pharmaceuticals in African water resources: A current status
Lawrence Mzukisi Madikizela et al.
JOURNAL OF ENVIRONMENTAL MANAGEMENT (2020)
The accessibility of data on environmental risk assessment of pharmaceuticals - are environmental risk assessments information on emissions with respect to international and European environmental information law?
Kim Oelkers
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
Yvan Jamilloux et al.
AUTOIMMUNITY REVIEWS (2020)
Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies
Ming Zhao
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Antibiotic residues in final effluents of European wastewater treatment plants and their impact on the aquatic environment
Sara Rodriguez-Mozaz et al.
ENVIRONMENT INTERNATIONAL (2020)
Anti-inflammatory drugs in the marine environment: Bioconcentration, metabolism and sub-lethal effects in marine bivalves
Angela Almeida et al.
ENVIRONMENTAL POLLUTION (2020)
Evolution of antibiotic resistance at low antibiotic concentrations including selection below the minimal selective concentration
Isobel C. Stanton et al.
COMMUNICATIONS BIOLOGY (2020)
The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic
Jung-Hyun Won et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Environmental Risk Assessment for rVSVΔG-ZEBOV-GP, a Genetically Modified Live Vaccine for Ebola Virus Disease
Joan G. Tell et al.
VACCINES (2020)
COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic
Valamla Bhavana et al.
LIFE SCIENCES (2020)
Pharmacology beyond the patient - The environmental risks of human drugs
Lina Gunnarsson et al.
ENVIRONMENT INTERNATIONAL (2019)
Occurrence, spatial-temporal distribution and ecological risks of pharmaceuticals and personal care products response to water diversion across the rivers in Nanjing, China
Haohan Yang et al.
ENVIRONMENTAL POLLUTION (2019)
Occurrence and ecotoxicological assessment of pharmaceuticals: Is there a risk for the Mediterranean aquatic environment?
Fanny Desbiolles et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2018)
Evaluation of acute and sublethal effects of chloroquine (C18H26CIN3) on certain enzymological and histopathological biomarker responses of a freshwater fish Cyprinus carpio
Mathan Ramesh et al.
TOXICOLOGY REPORTS (2018)
In Vitro Biotransformation of Two Human CYP3A Probe Substrates and Their Inhibition during Early Zebrafish Development
Evy Verbueken et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Pharmaceuticals in the environment - A short review on options to minimize the exposure of humans, animals and ecosystems
Stephanie Klatte et al.
SUSTAINABLE CHEMISTRY AND PHARMACY (2017)
Environmental Risk Assessment of Pharmaceutical Mixtures: Demands, Gaps, and Possible Bridges
Thomas Backhaus
AAPS JOURNAL (2016)
Risk assessment of down-the-drain chemicals at large spatial scales: Model development and application to contaminants originating from urban areas in the Saint Lawrence River Basin
Guenther Grill et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2016)
Improving Environmental Risk Assessment of Human Pharmaceuticals
Marlene Agerstrand et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2015)
Prediction, risk and control of anti-influenza drugs in the Yodo River Basin, Japan during seasonal and pandemic influenza using the transmission model for infectious disease
Takashi Azuma et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2015)
Occurrence of selected pharmaceuticals at drinking water purification plants in Japan and implications for human health
Dai Simazaki et al.
WATER RESEARCH (2015)
Detection of Peramivir and Laninamivir, New Anti-Influenza Drugs, in Sewage Effluent and River Waters in Japan
Takashi Azuma et al.
PLOS ONE (2015)
Antiretroviral Therapy Current Drugs
Alice K. Pau et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2014)
Characterization of Ritonavir-Mediated Inactivation of Cytochrome P450 3A4
Brooke M. Rock et al.
MOLECULAR PHARMACOLOGY (2014)
Effects of a glucocorticoid receptor agonist, dexamethasone, on fathead minnow reproduction, growth, and development
Carlie A. LaLone et al.
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY (2012)
Environmental release of oseltamivir from a Norwegian sewage treatment plant during the 2009 influenza A (H1N1) pandemic
Henriette Leknes et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2012)
Assessing the Ecotoxicologic Hazards of a Pandemic Influenza Medical Response
Andrew C. Singer et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
THE EFFECT OF pH ON THE UPTAKE AND TOXICITY OF THE BIVALENT WEAK BASE CHLOROQUINE TESTED ON SALIX VIMINALIS AND DAPHNIA MAGNA
Cecilie Rendal et al.
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY (2011)
Antiretroviral drug toxicity in relation to pharmacokinetics, metabolic profile and pharmacogenetics
Mona Arab-Alameddine et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Antiviral Drugs in Wastewater and Surface Waters: A New Pharmaceutical Class of Environmental Relevance?
Carsten Prasse et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2010)
Antiviral pandemic risk assessment for urban receiving waters
J. B. Ellis
WATER SCIENCE AND TECHNOLOGY (2010)
Environmental risk assessment of ivermectin: A case study
Markus Liebig et al.
Integrated Environmental Assessment and Management (2010)
Corticosteroids disrupt amphibian metamorphosis by complex modes of action including increased prolactin expression
Claudia Lorenz et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY (2009)
An environmental risk assessment for oseltamivir (Tamiflu (R)) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions
Juerg Oliver Straub
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2009)
Extending the environmental risk assessment for oseltamivir (Tamiflu®) under pandemic use conditions to the coastal marine compartment
Thomas H. Hutchinson et al.
ENVIRONMENT INTERNATIONAL (2009)
Autophagic and lysosomal reactions to stress in the hepatopancreas of blue mussels
Michael N. Moore et al.
AQUATIC TOXICOLOGY (2007)
Ecotoxicological evaluation of the antimalarial drug chloroquine
JL Zurita et al.
AQUATIC TOXICOLOGY (2005)
Share Paper
